These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 2442074)
1. Intensive induction and consolidation chemotherapy for adults and children with acute myeloid leukaemia (AML) joint AML trial 1982-1985. Marcus RE; Catovsky D; Prentice HG; Newland AC; Chessells JM; Stevens RF; Hann IM; Goldman JM; Hoffbrand AV; Galton DA Haematol Blood Transfus; 1987; 30():346-51. PubMed ID: 2442074 [No Abstract] [Full Text] [Related]
2. The ninth British Medical Research Council trial for the treatment of acute myeloid leukaemia. Rees JK; Gray R; Hayhoe FG Haematol Blood Transfus; 1987; 30():35-7. PubMed ID: 2442075 [No Abstract] [Full Text] [Related]
3. Remission induction and postremission therapy in acute myelogenous leukemia: British MRC Study. Rees JK; Gray RG Haematol Blood Transfus; 1990; 33():243-8. PubMed ID: 1691131 [No Abstract] [Full Text] [Related]
4. Amsacrine, cytarabine and thioguanine (AAT) versus daunorubicin, cytarabine, thioguanine (DAT) in adults with untreated acute non-lymphoblastic leukemia (ANLL). Austrian-German results. Linkesch W; Michlmayr G; Gerhartz H; Illinger H; König H; Düllmann J; Keilhauer R; Moldrzyk D Onkologie; 1989 Feb; 12(1):8-10. PubMed ID: 2654791 [TBL] [Abstract][Full Text] [Related]
5. Etoposide in remission induction of adult acute myeloid leukemia. Leoni F; Ciolli S; Patriarchi S; Morfini M; Rossi Ferrini P Acta Haematol; 1990; 83(2):82-5. PubMed ID: 2106200 [TBL] [Abstract][Full Text] [Related]
6. Long-term follow-up of a randomized post-induction therapy trial in acute myelogenous leukemia (a Southeastern Cancer Study Group trial). Volger WR; Weiner RS; Moore JO; Omura GA; Bartolucci AA; Stagg M Leukemia; 1995 Sep; 9(9):1456-60. PubMed ID: 7544851 [TBL] [Abstract][Full Text] [Related]
7. Preliminary results of intensive therapy of children and adolescents with acute nonlymphocytic leukemia--a Childrens Cancer Study Group report. Lampkin BC; Woods WG; Buckley JD; Hammond GD Haematol Blood Transfus; 1990; 33():210-4. PubMed ID: 1691130 [No Abstract] [Full Text] [Related]
8. The childhood AML studies BFM-78 and -83: treatment results and risk factor analysis. Creutzig U; Ritter J; Riehm H; Budde M; Schellong G Haematol Blood Transfus; 1987; 30():71-5. PubMed ID: 3305225 [No Abstract] [Full Text] [Related]
9. [Intensification of chemotherapy of acute myeloid leukemia in children: report on the studies of the AML-BFM 78 and AML-BFM 83 protocols]. Creutzig U; Ritter I; Schellong G Gematol Transfuziol; 1991 Jan; 36(1):16-21. PubMed ID: 2065939 [No Abstract] [Full Text] [Related]
10. A multicentre study on intensive induction and consolidation therapy in acute myelogenous leukaemia. Kurrle E; Ehninger G; Freund M; Heil G; Hoelzer D; Link H; Mitrou PS; Ohl S; Queisser W; Schlimok G Blut; 1988 May; 56(5):233-6. PubMed ID: 3285914 [No Abstract] [Full Text] [Related]
11. Therapy of acute myelogenous leukemia in adults. Petti MC; Broccia G; Caronia F; Di Raimondo F; Fioritoni G; Ladogana S; Leone G; Liso V; Musso M; Neri A Haematol Blood Transfus; 1990; 33():249-53. PubMed ID: 2182417 [No Abstract] [Full Text] [Related]
12. Survival in 91 adults with acute myelogenous leukaemia treated with 1-6 intensive courses of chemotherapy. Evensen SA; Brinch L; Stavem P; Tjønnfjord G J Intern Med; 1992 Nov; 232(5):433-7. PubMed ID: 1453128 [TBL] [Abstract][Full Text] [Related]
14. Remission induction and maintenance modalities in acute myeloid leukemia: a multicenter randomized study. Marty M; Lepage E; Guy H; Bordessoule D; Desablens B; Harousseau JL; Guilhot F; Leverger G; Schaison G; Boiron M Haematol Blood Transfus; 1987; 30():50-6. PubMed ID: 3305217 [No Abstract] [Full Text] [Related]
15. Marked improvements in outcome with chemotherapy alone in paediatric acute myeloid leukemia: results of the United Kingdom Medical Research Council's 10th AML trial. MRC Childhood Leukaemia Working Party. Stevens RF; Hann IM; Wheatley K; Gray RG Br J Haematol; 1998 Apr; 101(1):130-40. PubMed ID: 9576193 [TBL] [Abstract][Full Text] [Related]
16. Principal results of the Medical Research Council's 8th acute myeloid leukaemia trial. Rees JK; Gray RG; Swirsky D; Hayhoe FG Lancet; 1986 Nov; 2(8518):1236-41. PubMed ID: 2878130 [TBL] [Abstract][Full Text] [Related]
17. Amsacrine, cytarabine and etoposide in the treatment of bad prognosis acute myeloid leukemia. Wahlin A Med Oncol Tumor Pharmacother; 1989; 6(3):199-205. PubMed ID: 2615524 [TBL] [Abstract][Full Text] [Related]
18. Improved outcome in childhood acute myeloid leukemia in Singapore with the MRC AML 10 protocol. Tan RM; Quah TC; Aung L; Liang S; Kirk RC; Yeoh AE Pediatr Blood Cancer; 2007 Mar; 48(3):262-7. PubMed ID: 16602120 [TBL] [Abstract][Full Text] [Related]
19. Intensive consolidation chemotherapy versus standard consolidation maintenance in acute myelogenous leukemia (AML) in first remission. An EORTC/GIMEMA phase III trial (AML8 B). The EORTC Leukemia Cooperative Group and the GIMEMA Group. Zittoun R; Liso V; Mandelli F; Rotoli B; de Witte T; Gattringer C; Resegotti L; Caronia F; Leoni P; Petti MC Leukemia; 1992; 6 Suppl 2():76-7. PubMed ID: 1578949 [No Abstract] [Full Text] [Related]